Pasithea Therapeutics Corp's total assets for Q1 2026 were $56.35B, an increase of 93450.52% from the previous quarter. KTTA total liabilities were $1.54B for the fiscal quarter, a 30621.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.